Coronary Artery Disease
Conditions
Brief summary
This is a prospective cross-sectional, single-center retinal imaging study expecting to enroll approximately 400 male and female subjects ≥ 18 years of age. Subjects having undergone clinically-indicated coronary angiography or coronary computed tomography angiography (CCTA) within one month of consent at the Montreal Heart Institute (MHI) will be screened for inclusion in the study.
Detailed description
This is a prospective cross-sectional, single-center retinal imaging study expecting to enroll aproximately 400 (280 CAD and 120 control) male and female subjects ≥ 18 years of age. Subjects having undergone clinically-indicated invasive coronary angiography or coronary computed tomography angiography (CCTA) within one month of signed consent will be screened for inclusion in the study. Subjects will be recruited at the Montreal Heart Institute (MHI). During the screening visit, the investigator will review inclusion/exclusion criteria and the following information will be collected: demographic data including age and sex, relevant medical history including risk factors (hypertension, diabetes, dyslipidemia, smoking and obesity), history of CAD, concomitant cardiovascular medications and laboratory tests (lipid profile, fasting glucose) Subjects who provide written informed consent will undergo cognitive evaluation and an ophthalmic examination to identify any ocular exclusion criteria. All eligible subjects will then undergo hyperspectral retinal imaging using a Metabolic Hyperspectral Retinal Camera (MHRC) Safety will be assessed through reporting of serious adverse events (SAEs) related to retinal imaging procedures.
Interventions
None listed
Sponsors
Montreal Heart Institute
Optina Diagnostics Inc.
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Ability and willingness to give written informed consent * Age 18 years or older at the time of informed consent * Stable (non-emergent) typical or atypical symptoms suspicious for CAD (e.g., chest pain, chest tightness, chest burning, shoulder pain, palpitations, jaw pain, or non-chest pain symptoms such as dyspnea or worsening effort tolerance. * Patients having undergone clinically-indicated invasive coronary angiography or coronary computed tomography angiography within one month before consent signature
Exclusion criteria
1. At Screening Visit 1: 1. Asymptomatic subjects 2. Previous coronary revascularization (e.g., coronary artery bypass graft surgery, stenting) 3. Subjects being evaluated for other cardiac diseases (e.g., valvular disease, cardiomyopathy) 4. Pregnant or breastfeeding women 2. At Study Visit 2 or Ocular
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sensitivity and specificity of a pre-specified classification model based on retinal imaging parameters | 1.5 year | Sensitivity and specificity of a pre-specified classification model based on retinal imaging parameters to discriminate between control subjects and subjects with CAD (defined as stenosis in at least one epicardial vessel of 50% or greater) as assessed by coronary angiography. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between retinal imaging parameters and the number of vessels with a stenosis of 50% or greater as assessed by coronary angiography. | 1.5 year | — |
| Correlation between retinal imaging parameters and the maximal severity of coronary artery stenosis as assessed by coronary angiography. | 1.5 year | — |
| Sensitivity and specificity of new classification models based on retinal imaging parameters | 1.5 year | Sensitivity and specificity of new classification models based on retinal imaging parameters to discriminate between control subjects and subjects with CAD (defined as stenosis in at least one epicardial vessel of 50% or greater) as assessed by coronary angiography. |
| Correlation between retinal imaging parameters and cognitive scores on the Montreal Cognitive Assessment (MoCA) and executive tasks | 1.5 year | — |
| Sensitivity and specificity, among CAD subjects, of a pre-specified classification model, as well as new classification models | 1.5 year | Sensitivity and specificity, among CAD subjects, of a pre-specified classification model, as well as of new classification models, based on retinal imaging parameters to discriminate between subjects with less severe CAD (less vessels with a stenosis of 50% or greater) and subjects with more severe CAD (more vessels with a stenosis of 50% or greater) as assessed by coronary angiography. |
Countries
Canada
Outcome results
None listed